-
Rams ace Nacua apologizes over 'antisemitic' gesture furor
-
McIlroy wins BBC sports personality award for 2025 heroics
-
Napoli beat Milan in Italian Super Cup semi-final
-
Violence erupts in Bangladesh after wounded youth leader dies
-
EU-Mercosur deal delayed as farmers stage Brussels show of force
-
US hosting new Gaza talks to push next phase of deal
-
Chicago Bears mulling Indiana home over public funding standoff
-
Trump renames Kennedy arts center after himself
-
Trump rebrands housing supplement as $1,776 bonuses for US troops
-
Harrison Ford to get lifetime acting award
-
Trump health chief seeks to bar trans youth from gender-affirming care
-
Argentine unions in the street over Milei labor reforms
-
Trump signs order reclassifying marijuana as less dangerous
-
Famed Kennedy arts center to be renamed 'Trump-Kennedy Center'
-
US accuses S.Africa of harassing US officials working with Afrikaners
-
Brazil open to EU-Mercosur deal delay as farmers protest in Brussels
-
Wounded Bangladesh youth leader dies in Singapore hospital
-
New photo dump fuels Capitol Hill push on Epstein files release
-
Brazil, Mexico seek to defuse US-Venezuela crisis
-
Assange files complaint against Nobel Foundation over Machado win
-
Private donors pledge $1 bn for CERN particle accelerator
-
Russian court orders Austrian bank Raiffeisen to pay compensation
-
US, Qatar, Turkey, Egypt to hold Gaza talks in Miami
-
Lula open to mediate between US, Venezuela to 'avoid armed conflict'
-
Brussels farmer protest turns ugly as EU-Mercosur deal teeters
-
US imposes sanctions on two more ICC judges for Israel probe
-
US accuses S. Africa of harassing US officials working with Afrikaners
-
ECB holds rates as Lagarde stresses heightened uncertainty
-
Trump Media announces merger with fusion power company
-
Stocks rise as US inflation cools, tech stocks bounce
-
Zelensky presses EU to tap Russian assets at crunch summit
-
Pope replaces New York's Cardinal Dolan with pro-migrant bishop
-
Odermatt takes foggy downhill for 50th World Cup win
-
France exonerates women convicted over abortions before legalisation
-
UK teachers to tackle misogyny in classroom
-
Historic Afghan cinema torn down for a mall
-
US consumer inflation cools unexpectedly in November
-
Danish 'ghetto' residents upbeat after EU court ruling
-
ECB holds rates but debate swirls over future
-
Pope replaces New York's Cardinal Timothy Dolan with little-known bishop
-
Bank of England cuts interest rate after UK inflation slides
-
Have Iran's authorities given up on the mandatory hijab?
-
Spain to buy 100 military helicopters from Airbus
-
US strike on alleged drug boat in Pacific kills four
-
Thailand strikes building in Cambodia's border casino hub
-
Protests in Bangladesh as India cites security concerns
-
European stocks rise before central bank decisions on rates
-
Tractors clog Brussels in anger at EU-Mercosur trade deal
-
Not enough evidence against Swedish PM murder suspect: prosecutor
-
Nepal's ousted PM Oli re-elected as party leader
Adding peanuts to young children's diet can help avoid allergy: study
Including peanuts in children's diets early in life could help stave off allergies against the legume, which can be fatal and affect swathes of youngsters globally, according to a new study Friday.
Researchers found that introducing peanut products to babies and infants, and gradually increasing exposure, led to greater tolerance for the common allergen.
The peer-reviewed study, published in The Lancet, involved 146 peanut-allergic children aged between zero and three over two-and-a-half years.
Of the group, 96 were given peanut protein powder every day, with the dose increasing progressively to the equivalent of six peanuts. The other children received a placebo of oat flour.
Twenty of the children who received peanut powder showed allergy remission, meaning no allergic reaction occurred six months after the therapy ended.
One child in the placebo group showed remission.
Six months after the treatment, the children in remission could tolerate a dose equivalent to 16 peanuts.
An additional 20 children who received peanut powder were considered 'desensitised', meaning they had a higher allergic threshold but were not considered in remission.
These children could tolerate a dose equivalent to between six and 12 peanuts six months after the treatment ended.
The youngest children in the study experienced remission the most often, and the best results were in those under 12 months.
"Very early interventions may provide the best opportunity to achieve remission", said co-author Stacie Jones.
- 'Considerable burden' -
Peanut allergies affect two percent of children in Western countries, according to the study, and can last a lifetime.
Affected children must avoid eating peanuts and have self-injectable adrenaline available to fight allergic shocks, which can be fatal if they are accidentally exposed.
Exposure can even occur when a child hugs someone who has just consumed peanuts.
"There are no treatment options, resulting in a considerable burden on allergic children and their caregivers to avoid accidental exposure," said co-author Wesley Burks.
"In severe cases, this can restrict peanut-allergic children's freedoms, particularly when it comes to navigating daycare or schools and public spaces where access to a safe diet is in jeopardy," he added.
Previous studies have produced similar results but the length of the latest studies makes it unique.
Although it provided important results, it may not reflect the behaviour of the children's bodies in real-world conditions.
The study was conducted under close medical supervision, and adrenaline injections were administered on 21 children during the trial.
W.Morales--AT